Charles River Laboratories International, Inc. (CRL)
Health Care ยท Services-Commercial Physical & Biological Research
Charles River Laboratories International, Inc. (CRL) is listed on the New York Stock Exchange, where its shares have traded since June 23, 2000. SentiSense covers Charles River Laboratories International, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Commercial Physical & Biological Research. Birgit Girshick is its chief executive officer. The company reports 19,700 employees, and its corporate website is www.criver.com.
About Charles River Laboratories International, Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Latest reported results
Charles River Laboratories reported revenue of $982.7 million for Q3 FY2026, down 2.2% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 556 institutions reported holding CRL, with 56.3 million shares worth $12.8 billion in aggregate. The largest reported holders were Vanguard, FMR and BlackRock.
More on CRL
- CRL sentiment: whether news and social coverage of Charles River Laboratories International, Inc. leans bullish or bearish, and the stories driving it.
- CRL ownership: all 556 reporting institutions, plus insider and congressional trades.
- CRL financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
Frequently asked questions
What does Charles River Laboratories International, Inc. do?
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services.
What sector is CRL in?
SentiSense classifies Charles River Laboratories International, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Commercial Physical & Biological Research.
Where does CRL stock trade?
Charles River Laboratories International, Inc. (CRL) is listed on the New York Stock Exchange, where its shares have traded since June 23, 2000.
Who is the CEO of Charles River Laboratories International, Inc.?
Birgit Girshick is the chief executive officer of Charles River Laboratories International, Inc..